The Effect of Macronutrient Restrictions on Gut Microbiome and Biochemical Parameters of Wistar Albino Rats

Abstract

Macronutrients serve as a source of energy for both gut microbiota and its host. An increase or decrease in macronutrients can either increase or decrease the composition of gut microbiota, leading to gut dysbiosis which has been implicated in many diseases state including non-communicable diseases. To achieve this, seven diets were formulated by restricting 60% of each macronutrient. These diets were fed on 42 albino rats (Wistar), divided into 7 groups of 6 rats each. Group 1 was fed on a normal laboratory chow diet (ND), group 2 received a fat-restricted diet (FRD), group 3 received a protein-restricted diet, (PFD), group 4 received a carbohydrate-restricted diet (CRD), group 5 received a protein and fat-restricted diet (PFRD), group 6 re-ceived a carbohydrate and fat-restricted diet (CFRD) and group 7 received a carbohydrate and protein-restricted diet (CPRD). Feed and water intake were given ad libitum and daily weight and food intake were recorded. The experiment went on for 4 weeks after which animals were sacrificed and intestinal content and blood were collected for analysis (gut microbial composition, glucose, insulin levels, serum lipid, and enzyme). Compared to the control group results showed a decrease in Bacteroides (40.50 - 14.00 CFU), HDL (68.20 - 40.40 mg/dl), and AST (66.62 - 64.74 U/L) in FRD. An increase in AST (66.6 - 69.43 U/L), Bifidobacterial (59.50 - 92.00 CFU) and decreased Bacteroides (40.5 - 19.5 CFU) for PRD was also recorded. CRD reduced Lactobacillus (73 - 33.5 CFU), total bacterial count (129 - 48 CFU), HDL (68.2 - 30.8 mg/dl), and cholesterol (121.44 - 88.65 mg/dl) whereas intestinal composition of E. coli (30.5 - 51.5 CFU) increased. PFRD increased Lactobacillus (73.00 - 102.5 CFU), Bifidobacterial (59.5 - 100 CFU), HDL (68.2 - 74.7 mg/dl), and Triglyceride (111.67 - 146.67 mg/dl) concentration. Meanwhile, a reduction in Bifidobacterial (59.5 - 41.5 CFU), and an increasing of AST (66.62 - 70.30 U/l) were recorded for CFRD. However, Bacteroides (40.5 69.5 CFU), LDL (30.95 - 41.98 mg/dl) increased and Bifidobacterial (59.5 - 38.00 CFU) and HDL (68.2 - 53.5 mg/dl) decreased for CPRD. This work, therefore, concludes that macronutrient restriction causes significant changes in serum marker and enzyme profile, and gut microbial composition which can cause gut dysbiosis and later on could expose the host to inflammatory diseases in the long run.

Share and Cite:

Shu, B. , Tiencheu, B. , Djikeng, F. , Tiepma, D. , Feumba, D. , Epanty, Y. , Mbongo, L. and Achidi, A. (2024) The Effect of Macronutrient Restrictions on Gut Microbiome and Biochemical Parameters of Wistar Albino Rats. Journal of Biosciences and Medicines, 12, 286-310. doi: 10.4236/jbm.2024.126024.

1. Introduction

Macronutrients are the main source of energy for both humans and microorganisms found in their gut. These microorganisms are termed gut microbiota. Humans acquire this gut microbiota during and after birth, in infancy and toddler years [1]. Several factors affect the gut microbiota composition. These include diet, host genetics, use of antibiotics, diseases, aging, and environmental factors [2]. The gut microbiota plays several functions such as harvesting energy from food, improving gut transit and function, protecting against pathogens, producing vitamins and hormones, and other metabolites. An imbalance in the gut microbiota ecosystem is termed microbiota dysbiosis which is caused by several factors including diet [3]. Gut microbiota dysbiosis has been observed in many inflammatory diseases of the gastrointestinal tract (GIT) and organs linked to the track, either metabolically or immunologically. Interestingly, diet appears to be the most important determinant of gut microbial composition [4]. Short-term dietary interventions in healthy humans lead to significant and rapid alterations in the composition of the intestinal microbiota, but the magnitude of these effects is modest, relative to inter-subject variability [5].

A recent study shows that macronutrient composition and feeding paradigm result in a significant alteration in gut microbiota composition. These changes may improve physiological and cognitive outcomes following dietary implementation for both healthy and diseased humans [6]. Another study suggests that dietary fat has a beneficial role in serum lipid levels by lowering serum triglyceride levels and TC: HDL-C ratio, whereas carbohydrate intake was adversely associated with lipid profile by decreasing serum HDL-C concentrations [7]. According to Mutner et al. restricting protein decreases the intake of saturated fatty acid, fat cholesterol, and insulin resistance [8].

Given the worldwide epidemic of diet-related chronic diseases, evidence-based dietary recommendations are fundamentally important for health promotion. Despite the importance of the human gut microbiota for the physiological effects of diet and chronic disease etiology, national dietary guidelines around the world are just beginning to capitalize on scientific breakthroughs in the microbiome field [8] [9]. It will therefore be time to rethinking healthy eating in light of the gut microbiome. Nevertheless, the available evidence is strongly in support of an important role of the gut microbiome in the effects of diet, emphasizing that a mechanistic understanding of diet-microbiome interactions can inform nutrition controversies and advance the development of healthier diets. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome can be derived from gut studies and will present a variety of considerations including both practical recommendations that can be immediately incorporated into studies and aspirational recommendations that will require greater effort for implementation. It is difficult to determine which foods are the most promising candidates for intervention trials. Studies with strong dietary data collection methods will therefore play an important role in identifying potential diet-derived bioactive compounds and their food sources that can be investigated more closely with well-designed interventional studies [9].

Non-communicable diseases (NCD) such as cancer cardiovascular disease and diabetes are increasingly becoming the main cause of death in sub-Saharan Africa where these diseases were responsible for 37% of deaths in 2019 rising from 24% in 2000 [WHO]. In Cameroon, statistics show that cardiovascular diseases account for most deaths [9]. The natural homeostasis of the gut microbial community changes during many disease pathologies including obesity, metabolic syndrome, diabetes, cardiovascular disease, and celiac disease. In many cases, there is evidence implicating gut dysbiosis to these diseases. The evolution of diet over time caused by factors such as changes in food availability, food prices, and level of income, has forced individuals to replace traditional plant-based diets to diets high in sugars, animal fat, and food additives which are largely associated with gut dysbiosis [10]. The growing use of pesticides in agriculture can cause accidental chemical consumption such as lingering pesticides on washed fruits which can cause gut dysbiosis [11]. The development of new medications such as antibiotics affects the gut microbiota leading to rapid and diminishing levels of gut flora that leads to gut dysbiosis [12]. What effect does restricting macronutrients have on gut microbiota, lipid profile, and serum enzyme activities? This work aimed at evaluating the effect of macronutrient restricted diet on the gut microbiota load and biochemical parameters of non-communicable disease in Wistar rats.

2. Materials and Methods

2.1. Study Design

This is a laboratory-based study, conducted on different formulated macronutrient restricted diets using Wistar albino rats as the experimental model for a period of 4 weeks.

2.2. Ethical Clearance

Ethical clearance approval was obtained from the University of Buea-Institution for Animal Care and Use Committee (UB-IACUC) with permit Number: UB-IACUC N˚ 02/2023.

2.3. Feed Formulation

Ingredients for the formulation of various diets were bought from the local market located at Great Soppo, Buea South-west Region. These include: Soybean oil, corn-starch, Fish meal, corn fiber, Mineral mix (AIN-93G-MX), Vitamin Mix (AIN-93VMX). The ingredients were transported to the teaching laboratory of the Department of Biochemistry and Molecular Biology, University of Buea, where the formulation was made. The appropriate weights of various ingredients were measured using an electronic balance according to Table 1. The ingredients were mixed appropriately in a large bowl. After obtaining a homogenous mixture, each diet was sealed using an airtight zip lock plastic and kept in a dry clean container ready for use. The seven diets were isocaloric (3677 kcal), the primary distinguishing feature being protein, fat and carbohydrate content. The required macronutrient distribution in the seven diet groups was achieved by replacing a proportion of energy derived from carbohydrate (mainly corn starch) with fats (mainly soybean oil) and protein (mainly fishmeal). Same distribution was done for fat and protein. Each diet was formulated per kg.

2.4. Study Design

This is a laboratory-based study, conducted on different formulated macronutrient restricted diets using Wistar albino rat as the experimental model for a period of 4 weeks.

Table 1. Composition of diet in g/1000 for the different groups.

GROUP

Ingredient

1

2

3

4

5

6

7

ND

FRD

PRD

CRD

PFRD

CFRD

CPRD

Cornstarch (g)

529

589.3

609.7

211.6

709.4

211.6

211.6

Fish meal (g)

200

222.8

80

441.1

80

671.9

80

Sugar(g)

100

111.4

115.2

40

134.1

40

40

Soybean oil (g)

70

28

80.7

130.5

28

28

291.1

Fiber (g)

56

56

56

56

56

56

56

Mineral (g)

35

35

35

35

35

35

35

Vitamin (g)

10

10

10

10

10

10

10

ND: Normal diet, FRD: Fat restricted diet, CRD: Carbohydrate restricted diet, PRD: protein restricted diet, PFRD: Protein and fat restricted diet, CFRD: Carbohydrate and fat restricted diet, CPRD: Carbohydrate and protein restricted g: grams. Source: adapted from [14].

2.5. Experimental Animals

A total of forty-two (21 males and 21 females) albino rats (Weight: 130 - 180 g) used for this study were purchased from animal house of the Department of Animal Biology at the University of Yaounde. They were housed in the animal house at the University of Buea and maintained under standard conditions of temperature (22˚C) and 12 h light/dark cycle. They were acclimatized to laboratory conditions for a period of one week and all rats had access to normal laboratory chow feed (22% protein, 62 % carbohydrate, and 16 % fat) and water ad libitum during the experimental period.

2.6. Experimental Design

The experiment was carried out using the method described by Liu et al. [13]. The rats were randomly distributed into seven (7) groups of six (3 males and 3 females per group) animals each. They had access to their respective diet (s) and water ad libitum. During the experiment, their daily feed intake and body weight were evaluated and the mean was calculated. The experiment lasted for 28 days.

2.7. Weight and Food Intake

Food intake and weight were measured daily during the experiment. This was done by briefly removing the rats from their cages and weighing them, and the amount of food remaining (including any on the bottom of the cages or any that had spilled onto plastic sheets placed under each cage), was recorded. Intake was calculated as the weight (in grams) of food provided minus food left in the cage. Individual weights of all rats were measured using an electronic balance.

2.8. Collection, Processing and Samples for Analysis

2.8.1. The Oral Glucose Tolerance Test

On the 28th day of the experiment, the animals were fasted overnight after which the blood glucose was measured using a glucometer and denoted as fasting glucose (baseline glucose at t0) before administering glucose (2 g/kg). After that further measurements were made at a regular interval of 15, 30, 60 and 120 minutes.

2.8.2. Insulin Levels

Insulin levels were measured using fluorecare insulin kit according to the manufacturer instructions. The principle of the immune-chromatographic assay is used to detect the concentration of insulin in serum or plasma by double antibody sandwich method. Insulin in the specimens is combined with the fluorescent antibody on the bonding pad, and an insulin antibody complex is formed. Because of the effect of the chromatography, Insulin-antibody complex will be diffused along the nitrocellulose membrane. In the test line (T) region, the insulin-antibody complex is to be combined with coated antibody in the dictation area. The higher the concentration of insulin, the more the aggregation of the complex on the detection line the deeper the color of the fluorescent band under the specific wavelength.

2.8.3. Collection of Blood and Serum Preparation

On the 29th day, blood was collected from the heart of the overnight fasted rats under chloroform anesthesia. The blood collected was allowed to clot and centrifuged at 4000 rpm for 15 min at room temperature to obtain the serum. The blood serum was kept in a refrigerator at 0˚C - 4˚C until it was used.

2.8.4. Collection of Intestinal Contents

In a sterile environment, the feces found in the intestine were gently brushed off the wall of the intestine, from the jejunum to the rectum and then stored at −20˚C for further analysis.

2.9. Microbial Analyses

2.9.1. Sterilization and Aseptic Techniques

All glasswares were washed thoroughly with detergent, rinsed and sterilized at 121˚C at 15 psi for 15 minutes. The working surface was disinfected with 70% (v/v) alcohol. All media were prepared according to manufacturer instruction, sterilized at 121˚C at 15 psi for 15 minutes. The mouth of each flask was flame sterilized before pouring the media into the sterile petri dishes.

2.9.2. Preparation of Inoculum

About 1 g of each sample was diluted up to ten folds in sterile test tube containing 9 ml of 0.85% saline solution (NaCl). About 100 micrograms of 2 different dilution factors 105 and 106 were pipetted into the plate.

2.9.3. Preparation of Different Culture Media

For the preparation of the different culture media, the different constituents of the medium were weighed, put in a glass jar and then poured in distilled water according to the volume prepared. Then the mixture was then autoclaved at 121˚C, 15 psi for 15 and then cooled before pouring into each petri dish. Each medium was prepared in 500 ml of water.

Preparation of media for Escherichia coli

About 18.5 g of Eosin Methylene Blue was measured into a glass jar and 500 ml of distilled water was poured into it. The mixture was autoclaved at 15 psi for 15 min. The mixture was left to cool before pouring into each petri dish.

Preparation of media for Bacteroides media

Brain heart infusion agar media (BHI) was supplemented for the growth of Bacteroides. About 18.5 g of BHI, 2.5 g of yeast extract and 500 ml of water were measured into a glass jar. The mixture was autoclaved at 121˚C, 15 psi for 15 min. The mixture was cooled and 0.25 ml of blood, 0.5 mg of menadione, 20 ml of vancomycin and 0.2 mg of gentamicin were then added.

Preparation of media for bifidobacterial

Man Regosa Sharpe (MRS) agar media was to culture Bifidobacterial. The media was supplemented with L cysteine, tween 80 and cyclohexamide. About 26 g of MRS, 0.5 ml of tween 80 and 500 ml of water were measured into a glass jar and the mixture was autoclaved at 121˚C, 15 psi for 15 min. When the mixture was cooled, 25 mg of Lcysteine, and 2 ml of cyclohexamide were added.

Preparation media for lactobacillus

Man Regosa Sharpe (MRS) agar media supplemented with tween 80 and cyclohexamide was used in culturing Lactobacillus. About 26 g of MRS agar, 0.5 ml of tween 80 and 500 ml of distilled water were measured into a glass jar. The mixture was then autoclaved 121˚C, 15 psi for 15 min. When the mixture was cooled, 2 ml of cyclohexamide was added to the mixture.

Total bacterial count

Plate count agar was used to quantify the total bacteria in the fecal sample. About 10 g of plate count agar and 500 ml of distilled water were measured into a glass jar. The mixture was autoclaved at 121˚C, 15 psi for 15 min. The mixture was cooled before it was poured into a petri dish.

2.9.4. Sowing

1) Surface Seeding

Seeding was done in one layer and consisted of placing 1 ml of sample in a Petri dish before introducing the culture medium. This type of seeding is ideal for strains such as Escherichia coli.

2) Immersion

Here the seeding was done with a double layer. This type of seeding is suitable for anaerobes; a quantity of culture medium was introduced into the petri dish and then left to solidify, then 1 ml of sample was introduced. Finally, the culture medium was further added and left to solidify. This type of seeding is ideal for the growth of Bacteroides, Bifidobacterial, and Lactobacilli. All the petri dishes were later sealed to prevent oxygen since these bacteria are anaerobes. All petri dishes were incubated 37˚C for 24 for the EMB, Plate Count agar, BHI media, MRS and MRS+ cysteine agar.

2.9.5. Plate Count

After bacterial growth was seen on the surface of the media, the CFU (colony forming unit) was obtained by counting the number of bacterial colonies found on the media and inserting the values into the formula below [15].

CFU = number of bacterial colonies × dilution factor volume of inoculum used

2.9.6. Characterization of the Isolates

1) Catalase test

Catalase is an enzyme produced by most micro-organism that breaks down hydrogen peroxide into water and oxygen which produces gas bubbles [16].

2 H 2 O 2 2 H 2 O 2 + O 2

The test was done by placing a drop of 3% hydrogen peroxide solution onto a slide. Using a sterilized needle, a colony was randomly chosen from a media and placed into the drop. The isolate which did not give gas bubbles was characterized as catalase negative, those that produced bubbles were characterized as positive [16].

2) Gram staining

Gram staining is important in identifying and classifying bacteria depending on their characteristic. The principle is based on the ability of the cell walls to retain stain. Isolates were collected from the colony that was chosen for catalase test. The bacteria were fixed onto a slide by placing a loop full of water onto the slide. The loop was sterilized by placing the loop on to the flame until it bright hot then allowed to cool down. Using this loop, the colony that was chosen for the catalase test was scraped and smeared onto the slide. They were left to air dry and the bacteria were fixed by passing it over a flamed 3 times. Crystal violet (primary slide) was applied onto the slide for 30 to 60 s to color the slide purple. The slides were then washed away with running water to stop the reaction. Lugol iodine (mordant) was then applied for 30 to 45 s and washed off using running water 70% alcohol was used to decolorize the bacteria by removing the excess stain. The slides were then washed with running water to stop the reaction. Diluted safranin was added to the slide for 10 to 15 s and then washed off with running water. The slides were then air-dried. The prepared slides were then observed under the light microscope with the magnification of 100× using immersion oil. Bacteria which has pink color were gram-negative and those of purple color were gram-positive.

2.10. Biochemical Analysis of Serum

2.10.1. Estimation of Lipid Profile

The triglyceride and total Cholesterol levels were determined by the Buccolo colorimetric method using Chrono lab test kit [17]. The very low density (VLDL) and low density (LDL) lipoproteins from serum or plasma were precipitated by phosphotungstate in the presence of magnesium ions. After centrifugation, the supernatant containing high density lipoproteins (HDL) was determined using the total cholesterol enzymatic reagent [18]. LDL-cholesterol was calculated from measured values of total cholesterol, triglycerides and HDLcholesterol according to the relationship: [LDL-chol] = [total chol] − [HDL-chol] − [TG]/5 and [TG]/5 was an estimate of VLDL-cholesterol.

2.10.2. Estimation of Serum Enzymes

The activity of (ALP) was determined by the Reitman and Frankel colorimetric [19] UV Kinematic determination of alkaline phosphatase in serum based upon IFCC recommendation using INMESCO test kit. Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST) were measured using the chrono lab enzymatic kit [20]. The concentration of creatinine was estimated using chrono lab enzymatic kit [21].

2.11. Statistical Analysis

Analysis was done in duplicates. The various data collected was imported into Microsoft Excel where the mean and standard deviation were calculated. The data was then subjected to one-way analysis of variance (ANOVA), using GraphPad InStat version 3.10 in order to evaluate the statistical significance of the mean. Student-Newman-Keuls tests were used to calculate the significant difference. The result of this test was presented in tables and figures. A probability value at p < 0.05 was considered statistical significance.

3. Results

3.1. Food Intake

The weekly food intake for rats fed with restricted and normal diets is represented in Table 2. Generally, a significant (p < 0.05) increase in food intake was recorded with all groups during the four weeks except for carbohydrate and fat restricted diet and carbohydrate and protein restricted diet which food intake increased right up to the third week before significantly decreasing the fourth week.

Table 2. Weekly food intake of feed in grams.

Groups

Week1

Week2

Week3

Week4

ND

34.76 ± 3.92b

48.00 ± 9.33cd

50.00 ± 10.00b

60.86 ± 6.87bc

FRD

41.70 ± 10.42b

41.71 ± 7.93c,d

50.57 ± 7.73b

53.14 ± 15.13b

PRD

34.34 ± 7.78b

26.86 ± 9.20a,b

47.43 ± 7.97b

53.71 ± 8.15b

CRD

43.40 ± 9.90b

52.00 ± 11.63d

46.57 ± 6.77b

66.29 ± 11.65bc

PFRD

38.22 ± 13.44b

36.00 ± 10.26abcd

46.57 ± 8.55b

70.00 ± 9.05bc

CFRD

51.20 ± 2.12b

55.43 ± 8.32d

65.29 ± 2.87c

76.00 ± 7.72c

CPRD

13.12 ± 8.31a

22.86 ± 1.99a

24.86 ± 4.92a

18.86 ± 3.55a

N = 4, all values assigned the same letter are not significantly different from each order at p < 0.05 while those assigned different letters are significantly different at p < 0.05, ND: Normal diet, FRD: Fat restricted diet, CRD: Carbohydrate restricted diet, PRD: protein-restricted diet PFRD: Protein and fat restricted diet, CFRD: Carbohydrate and fat restricted diet.

The food intake among groups showed that carbohydrate and protein restricted diet (CPRD) presented the lowest (p < 0.05) values on week one. In the second week protein restricted diet (PRD), and carbohydrate and protein restricted (CPRD) showed the lowest (p < 0.05). In the third week carbohydrate and fat restricted diet (CFRD) reported a significantly higher food intake compared to the other groups while carbohydrate and protein restricted diet (CPRD) presented the lowest value. In the last week carbohydrate and protein restricted diet (CPRD) was the group with the lowest food intake compared to the other ones.

3.2. Weekly Weights

The average body weights (weekly basis) of the different groups of rats are presented in Figure 1. A significant (p < 0.05) decrease in body weight was registered in all groups, except for the control group where this parameter was significantly increased.

Figure 1. The effect of macronutrient restriction on weight of rats.

3.3. Insulin Levels

The insulin level is presented in Figure 2. About 50% of the test groups had insulin levels that were either high or low compared to the control group. Insulin levels were found to be significantly (p < 0.05) lower in the carbohydrate and fat restricted (CFRD), and carbohydrate and protein restricted (CPFD) groups while a significant (p < 0.05) increase was recorded in protein and fat restricted groups compared to the normal.

n = 2, Values are expressed as mean ± standard deviation. The values assigned the same super-script are significantly not different (p ≤ 0.05) from each other and those assigned different superscripts are significantly different; ND Normal diet, FRD: Fat restricted diet, CRD: Carbohydrate restricted diet PFRD: Protein and fat restricted diet, CFRD: Carbohydrate and fat restricted diet, CPRD: Carbohydrate and protein restricted diet. CFU: Colony forming unit.

Figure 2. Insulin levels for rats fed with macronutrient restricted diet.

3.4. Oral Glucose Tolerance Test

The oral glucose test is presented in Figure 3. Generally, the glucose levels of all groups increased after admission of glucose (2 g/kg body weight) except for the control group and decreased as time progressed. A significant (p < 0.05) difference in the oral glucose tolerance was found among the groups. Protein restricted diet (PFRD) recorded a significantly (p < 0.05) higher fasting glucose level than the rest of the group. After glucose administration the carbohydrate restricted diet record a significantly (p < 0.05) higher glucose level.

Figure 3. Oral glucose concentration of rats fed with restricted die.

3.5. Microbial Analysis

3.5.1. Cultural Characteristics of the Bacteria Isolates

Table 3 shows the morphological characteristics of isolates such as margin, elevation, shape and color. All colonies were round, entire and flat except for the lactobacillus colonies that were convex. Colonies that grew in the Brain Heart Infusion Agar (BHI) and the Man Regosa Sharpe (MRS) + Cysteine agar were red in color and those in the Eosin methylene blue (EMB) and Man Regosa Sharpe (MRS) were black and white in color respectively.

3.5.2. Biochemical Characteristics of the Isolates

The biochemical characteristics of the isolates such as catalase test and gram stain are described in Table 4. The catalase test reveals that all colonies formed on the culture media were catalase negative except for those formed on brain heart infusion agar (BHI). Colonies formed on Man Regosa Sharpe (MRS) and Man Regosa Sharpe (MRS) + cysteine agar were gram positive while those formed on Eosin methylene blue (EMB) and Brain Heart Infusion (BHI) were gram negative. When viewed under the microscope all isolates appeared to be rod shaped except isolates from MRS + cysteine which where branched rods.

Table 3. Colony morphology.

Culture
medium

Morphology isolates

ND

FRD

PRD

CRD

PFRD

CFRD

CPRD

BHI

Color

Red

Red

Red

Red

Red

Red

Red

Elevation

Flat

Flat

Flat

Flat

Flat

Flat

Flat

Shape

Round

Round

Round

Round

Round

Round

Round

Margin

Entire

Entire

Entire

Entire

Entire

Entire

Entire

MRS agar + cysteine

Color

Red

Red

Red

Red

Red

Red

Red

Elevation

Flat

Flat

Flat

Flat

Flat

Flat

Flat

Shape

Punctiform

Punctiform

Punctiform

Punctiform

Punctiform

Punctiform

Punctiform

Margin

Entire

Entire

Entire

Entire

Entire

Entire

Entire

MRS agar

Color

White

White

White

White

White

White

White

Elevation

Convex

Convex

Convex

Convex

Convex

Convex

Convex

Shape

Round

Round

Round

Round

Round

Round

Round

Margin

Entire

Entire

Entire

Entire

Entire

Entire

Entire

EMB agar

Color

Black

Black

Black

Black

Black

Black

Black

Elevation

Flat

Flat

Flat

Flat

Flat

Flat

Flat

Shape

Circular

Circular

Circular

Circular

Circular

Circular

Circular

Margin

Entire

Entire

Entire

Entire

Entire

Entire

Entire

ND: Normal diet, FRD: Fat restricted diet, CRD: Carbohydrate restricted diet PRD: protein restricted diet PFRD: Protein and fat restricted diet, CFRD: Carbohydrate and fat restricted diet, CPRD: Carbohydrate and protein restricted diet.

Table 4. Biochemical characteristics of isolated gut microbiota.

Culture Medium

Catalase

Gram Stain

Shape

Culture Medium

Brain heart infusion

agar (supplemented)

+

Rods

Brain heart infusion

agar (supplemented)

MRS+ cysteine

+

Branched rods

MRS+ cysteine

MRS

+

Rods

MRS

EMB

Rods

EMB

EMB: Eosin Methylene Blue, MRS De Man, Rogosa and Sharpe.

3.5.3. Microbial Composition

The microbial analysis of rat fed with macronutrient restricted diet and a normal diet is presented in Table 5. The composition of Bacteroides was significantly (p < 0.05) decreased in the fat restricted (FRD) and protein restricted (PRD) groups. Meanwhile this parameter was significantly (p < 0.05) increased in the carbohydrate restricted (CRD) and carbohydrate and protein restricted (CPRD) groups compared to the control group. For Lactobacillus, its composition was increased (p < 0.05) in protein and fat restricted (PFRD) groups, and significantly (p < 0.05) decreased in the carbohydrate restricted group (CRD) compared to the control group. A significant (p < 0.05) increase in Bifidobacterial composition was recorded in the protein restricted (PRD) and protein and fat restricted (PFRD) groups compared to the normal. However, this parameter significantly (p < 0.05) decreased in the carbohydrate restricted CRD, carbohydrate and fat restricted (CFRD), and protein and fat restricted diet compared to the control group. Carbohydrate restricted (CRD) and carbohydrate and fat restricted (CFRD) groups recorded a significant (p < 0.05) increase in E. coli composition compared to the normal. The total bacterial count was significantly (p < 0.05) low in the carbohydrate restricted (CRD), carbohydrate and fat restricted (CFRD) and carbohydrate and protein restricted (CPRD) groups compared to the normal.

Table 5. Results for microbial analysis of bacteria isolates.

Groups

Bacteroides

Lactobacillus

Bifidobacterium

E. coli

TBC


(CFU)

(CFU)

(CFU)

(CFU)

(CFU)

ND

40.50 ± 6.36bc

73.00 ± 5.65b

59.50 ± 7.77b

30.5 ± 2.12a

129.50 ± 3.53c

FRD

14.00 ± 5.65a

60.00 ± 1.41b

63.50 ± 3.53b

26.5 ± 7.77a

139.50 ± 12.02c

PRD

19.00 ± 5.65a

71.50 ± 9.19b

92.00 ± 7.07c

29 ± 1.41a

148.00 ± 11.31c

CRD

52.50 ± 2.12c

33.50 ± 6.36a

47.00 ± 2.82a

51.5 ± 3.53b

48.00 ± 11.31ab

PFRD

39.50 ± 7.77bc

102.50 ± 4.94c

100.00 ± 2.82c

39.5 ± 0.70a

72.00 ± 11.31b

CFRD

22.50 ± 6.36ab

78.00 ± 4.24b

41.5.00 ± 3.53a

82.00 ± 8.48c

34.50 ± 6.36a,

CPRD

69.50 ± 9.19d

67.50 ± 3.53b

38.00 ± 2.82a

26.00 ± 2.82a

67.00 ± 7.07ab

n = 2, Values are expressed as mean ± standard deviation. The values assigned the same superscript are significantly not different (p ≤ 0.05) from each other and those assigned different superscripts are significantly different; ND Normal diet, FRD: Fat restricted diet, CRD: Carbohydrate restricted diet PFRD: Protein and fat restricted diet, CFRD: Carbohydrate and fat restricted diet, CPRD: Carbohydrate and protein restricted diet. CFU: colony forming unit.

3.6. Lipid Profile

The effect of restricting macronutrient on serum lipid profile is presented in Table 6. A significant (p < 0.05) increase in high density lipoprotein (HDL) was recorded in the rats fed with protein and fat restricted diet meanwhile carbohydrate and protein restricted (CPRD), carbohydrate and fat restricted (CFRD), fat restricted diet (FRD) and carbohydrate restricted diet (CRD) where significantly (p < 0.05) decreased. With Very low density lipoprotein (VLDL), carbohydrate and fat restricted diet (CFRD) was significantly decreased. Concerning low density lipoprotein (LDL) a significant (p < 0.05) increase was recorded in the protein restricted group compared to the control group. For cholesterol, a significant (p < 0.05) decrease was recorded in rats fed with carbohydrate restricted diet (CRD) compared to the normal. Protein restricted diet (PRD), carbohydrate restricted diet (CRD) and carbohydrate and fat restricted diet (CFRD) recoded significantly (p < 0.05) low values for triglycerides compared to the control while carbohydrate and protein restricted diet (CPRD) and protein and fat restricted diet (PFRD) values where significantly (p < 0.05) higher.

Table 6. The effect of macronutrient restriction on lipid profile.

Groups

HDL (U/L)

VLDL (U/L)

LDL (U/L)

Cholesterol (U/L)

TG (U/L)

ND

68.2 ± 7.5d

22.77 ± 5.88bc

30.95 ± 4.24a

121.44 ± 3.98bcd

111.67 ± 4.41c

FRD

40.4 ± 2.0b

23.13 ± 6.24bc

44.50 ± 8.56ab

108.83 ± 8.48abc

119.44 ± 3.54c

PRD

64.5 ± 1.4de

19.93 ± 4.42bc

49.97 ± 9.48b

134.41 ± 7.57cd

99.67 ± 12.02b

CRD

30.8 ± 4.7a

15.67 ± 1.22b

42.14 ± 7.65ab

88.65 ± 11.11a

78.33 ± 9.43a

PFRD

74.7 ± 1.9e

29.33 ± 4.19c

41.00 ± 6.91ab

145.05 ± 9.59d

146.67 ± 12.02d

CFRD

41.3 ± 3.5b

8.33 ± 0.19a

40.93 ± 5.89ab

97.39 ± 8.96ab

75.56 ± 0.96a

CPRD

53.5 ± 7.8c

31.00 ± 7.80c

41.98 ± 8.18ab

128.56 ± 14.31bcd

165.33 ± 2.36d

n = 4, The values are expressed as the mean ± standard deviation of the mean. The values assigned the same letter are not significantly different from each other while those assigned different letters are significantly different (p < 0.05) ND: Normal diet, FRD: Fat restricted diet, CRD: Carbohydrate restricted diet PFRD: Protein and fat restricted diet, CFRD: Carbohydrate and fat restricted diet, CPRD: Carbohydrate and protein restricted diet, HDL: high density lipoprotein, VLDL: very low density lipoprotein, LDL: low density lipoprotein, TG: triglyceride.

3.7. The Serum Enzymes and Other Biochemical Parameter

The effect of macronutrient restriction on serum enzyme is presented in Table 7. No significant difference was recorded between the creatinine value of the rats fed with nutrient restricted diet compared to the control group (ND). There was a general increase recorded in AST levels among all groups.

Table 7. The effect of macronutrient restriction on serum enzymes and other biochemical parameter.

Diets

Creatinine (mg/dl)

AST (µ/L)

ALT (µ/L)

ALP (µ/L)

ND

3.7 ± 1.3a,b

66.62 ± 4.92b

10.50 ± 4.12a

116.96 ± 10.41bc

FRD

4.4 ± 1.6a,b

64.74 ± 4.91b

15.60 ± 5.20a

150.63 ± 21.49e

PRD

3.7 ± 1.5a,b

69.43 ± 4.94b

14.29 ± 5.00a

103.65 ± 28.01a

CRD

3.1 ± 0.7a

59.41 ± 6.11a

19.69 ± 2.90a

152.48 ± 20.84e

PFRD

6.8 ± 3.3b

85.81 ± 3.31c

35.00 ± 5.89b

121.38 ± 37.78c

CFRD

2.9 ± 0.6a

70.30 ± 6.23c

14.72 ± 1.29a

112.86 ± 8.46b

CPRD

3.3 ± 1.0a

95.43 ± 6.24d

16.91 ± 2.38a

134.05 ± 20.19d

n = 4, the values are expressed as the mean ± standard deviation of the mean. The values assigned the same letter are significantly the same while those assigned different letters are significantly different (p < 0.05) ND: Normal diet, FRD: Fat restricted diet, CRD: Carbohydrate restricted diet PFRD: Protein and fat restricted diet, CFRD: Carbohydrate and fat restricted diet, CPRD: Carbohydrate and protein restricted diet, AST: Aspartate transaminase, ALT: Alanine transaminase, ALP: Alkaline phosphatase.

4. Discussion

4.1. Food Intake and Body Weight

The body needs macronutrients to provide energy, build and repair tissues, insulate organs and make cell membranes. In this study, ad libitum consumption of macronutrient restricted diet for 4 weeks produces a decrease in body weight compared to the control group despite an increase in food intake. Among all the groups that experienced weight loss, CPRD lost 15% of its weight during the experiment followed by CFRD group (10% of their weight). These two groups also had the highest (CFRD) and the lowest (CPRD) feed consumption. The weight loss experienced in the CFRD group is close to the low carbohydrate/high fat diet of Noakes et al. [22] and Ludwig et al. [23]. The weight loss in this group can be attributed to its high fat content. High fat diet is extremely satiating, help curb hunger and craving hence helps prevent overeating [22]. This also explains the low feed consumption of this group. The weight loss experienced by the CFRD groups mimics the high protein diet group of Westerter et al. [24]. This weight loss can be attributed to the fact that, high protein diet increases energy expenditure by increasing diet induced thermogenesis, which can lead to negative energy balance—a state of greater energy output than input [25]. The high food intake of this group could be the effect of high ghrelin experienced in high protein diet. Ghrelin is a hormone that increases appetite and Leidy et al. [26] found out that these hormone increase with high protein intake leading to a great frequency of food consumption. This also explains the high feed intake in this group.

4.2. Insulin Levels and Glucose Tolerance Test

The role of insulin in the blood is to regulate blood sugar level. The insulin level in this study was found to be higher in the PFRD group and lower in the CRFD and CPRD groups. The increase in the fasting insulin levels experienced in the PFRD group was inconsistent with that of Solon-Biet et al. [27]. They found that fasting insulin levels in mice decreased with increasing dietary carbohydrate content after 8 weeks on experimental diets [27]. Also, Axen and Axen [28] experienced higher fasting insulin levels when comparing a 6% carbohydrate diet with a chow diet that had 70% carbohydrate after 6 - 7 weeks of exposure. Similarly, the fasting insulin levels of rats were not strongly linked to dietary carbohydrate content between 5% and 60% carbohydrate intake [29]. The reason why the insulin level was high in this present study can be attributed to the high carbohydrate content of PFRD. The body strives to regulate the glucose produced during the break down of carbohydrate by releasing insulin.

Low levels of insulin found in the CPRD and CFRD are consistent with a study by Anne et al. that shows a decreased production of glucose in fasting state after both polyunsaturated fatty acid (PUFA) and saturated fatty acid (SFA) are ingested in high-fat diet [30]. An observational study by Linn et al. showed reduced insulin sensitivity, greater endogenous glucose production and greater net gluconeogenesis in high protein diets [31].

4.3. Microbial Analysis

One major function of gut microbiota is the breakdown of macronutrient to release metabolites that are useful to both the host and the microorganism itself. Bacteroides, Bifidobacterial, lactobacillus and E. coli are examples of these bacterial found in the gut. This microorganism show distinctive characteristic when cultured in the laboratory. In this study supplemented BHI agar was used to cultivate Bacteroides. Colonies formed where red, round flat and entire, which were negative on catalase test and were pink rods when viewed under the microscope. This is consistent with other studies that revealed that Bacteroides are gram negative rod [32], and catalase negative [33].

Both Bifidobacterial and Lactobacillus can be cultivated with MRS. These organisms can be differentiated when cysteine is added to the medium. This promotes the growth of Bifidobacteria that forms red punctiform colony, that is catalase negative and gram positive branched rods while lactobacillus forms white colonies that are round and convex, that are catalase negative and gram positive rods. Similar results were obtained in this study and also on infant feces by Biavati et al. [34]. EMB agar used in this study produced black, flat and round colonies which are catalase negative and gram-negative rods. The identification of E.Coli was consistent with those of Holt-Harris [35].

4.4. Microbial Composition

Diet is arguably one of the most important forces shaping the gut microbiota. Of all the factors influencing gut microbiota composition and function throughout all life stages, diet is key in modulating abundances of specific bacterial species and their functions [36]. The composition of some gut bacteria in this study changed when some macronutrients were restricted. The composition of Lactobacillus and Bifidobacterial increased when the proportion of carbohydrate in the diet was high and decreased when it was low. Matsumoto et al. [37], Priebe et al. [38] and Zhong et al. [39] reported similar results with humans fed with probiotic milk. Carvalho—Wells also reported an increase in intestinal Bifidobacteria and lactic acid bacteria when maize-based whole grain breakfast cereal is consumed [40]. The increase could be explained by the fact that, these organisms are saccharolytic bacteria that degrade carbohydrates as reported by Nordmann et al. [41]. Protein is an important source of essential nutrients and is necessary to maintain a normal body and health [42]. However, chronic consumption of protein can result in serious pathological and degenerative diseases involving gut microbiota [43]. In this study, the relative abundance of Bacteroides decreased in both PRD and CFRD groups. In addition to the decrease in the Bacteroide composition an increase in bifidobacterial and E. coli was seen in PRD and CFRD respectively. The decreased abundance of Bacteroides in the PRD group is in line with those of Mu et al. [44]. The CFRD in this study mimics the high protein diet group of Leidy et al. [26] and Mu et al. [44]. The increase in E. coli can be attributed to the fact that, high protein diet induces a reduction of both propionateand butyrate-producing bacteria and thus the production of propionate and butyrate [45]-[47]. These metabolites play a key role in inhibiting the growth of pathogens in the gut. the reduction of these bacteria in a high protein diet creates a favorable environment for the growth of pathogenic bacteria such as Escherichia, Enterococcus, and Streptococcus.

This study reveals a decrease in Bacteroides in FRD group but this microorganism increased in the CPRD group. The increase in Bacteroides in the CPRD group is consistent with the high-fat diet of Wu et al. [48] and Drasar et al. [49]. Both studies suggested that a high-fat diet increases total anaerobic microflora and counts of Bacteroides. In addition to the decrease in Bacteroide in the CPRD group, an increase in Bifidobacterial was also recorded. This confirms the results of Murphy et al. [50] and Lecomte et al. [51]. Lecomte et al. found out that a high-fat diet resulted in propionate and acetate producing bacteria (Clostridial, Bacteroides, and Enterobacterial) [26]. Murphy et al. [50] study in mice revealed a decrease in the bifidobacterial population. The result of this study could be explained by the fact that when dietary fat content is increased, there is usually a low content of other dietary compounds such as carbohydrates and fiber. Low carbohydrate and fiber diets could reduce energy substrates for beneficial bacteria growth such as bifidobacterial.

4.5. Micronutrient Restriction and Biochemical Parameters

In this study, macronutrient restriction had a great impact on HDL and triglyceride levels. Compared to the normal diet, HDL levels decreased with FRD, CRD, CFRD, and CPRD but increased with PFRD. A triglyceride reduction was recorded with PRD, CRD, and CFRD but increased with PFRD. Meanwhile, CRD and CFRD decreased cholesterol and very low-density lipoprotein respectably there was an increase in LDL levels but these increases were not significant except for PRD.

The decrease in HDL and total cholesterol reported in this study with CRD is consistent with those observed by Hu et al. [52] and Bazzano et al. [53]. A major concern that has been frequently raised about low-carbohydrate diets is their potential to elevate LDL cholesterol levels [54]. This study found an increase in LDL cholesterol levels among rats fed with low carbohydrate diet. However, this increase was not significant to the normal. Indeed, a high intake of total carbohydrate is associated with higher triglyceride concentrations in adults [55] and children [56]. In this study, the increase in triglyceride level was recorded in the PFRD. This finding is consistence with those of Parks et al. [57]. This increase can be attributed to an increase in triglycerides levels caused by increased dietary carbohydrates, particularly simple sugars and starches with high glycemic index [58].

The role of fat intake in serum lipid levels differs according to the type of fat consumed. Indeed, the fatty acid profile of the diet seems to be the major determinant of serum cholesterol concentrations. HDL levels decreased with FRD in this study. Alice et al. also found a negative association between low fat intake and HDL humans [59]. This decrease in HDL concentrations, presumably resulted in a decrease in fat intake [60]. High-fat (CPRD) for 28 days resulted in decreased levels of HDL and increased triglyceride in the rats. This result is consistent with those of Kalaivanisailaja et al. [60]. The increase in plasma triglyceride can be due to a decrease in the activity of lipoprotein lipase [60].

Focusing on proteins, the PRD group recorded an increase in LDL. This finding is in contrast to those recorded by Bruna et al. [61]. Fontes et al. observed a greater decrease in serum levels of total cholesterol and LDL-c in chronic kidney disease patients receiving low protein diet. A decrease in LDL was expected in this since a decreased intake of animal protein helps decrease serum cholesterol levels. The high protein group in this study recorded a decrease in HDL, VLDL, total cholesterol and triglyceride level. This finding is coherent with those of Lunacastilo et al. [62]. These decreases can be attributed to reduction in chylomicron formation due to decreased fat intake, faster chylomicron clearance by increasing LPL stimulation, effectiveness of lipid oxidation in the liver, and decreased lipid synthesis [63].

4.6. Serum Enzymes and Macronutrient Restriction

A remarkable increase in ALT in the PFRD was recorded in this study. This finding is consistent with those of Purlins et al. [64]. This could be due to the presence of high carbohydrate in this diet. An influx in carbohydrate directly affects ALT levels as this enzyme is involved in pyruvate metabolism [64]. The highest level of AST was recorded by CPRD in this study. This result is in accordance with the findings of Welch et al. [65] who showed an increased AST level with high fat diet in euthyroid and thyroid-altered rats. This increase can be due to dehydration and high protein content. This enzyme plays a key role in the metabolism of amino acids in all species [66]. The highest ALP value was recorded by the CRD group. This finding is in accordance with Zhou et al. [67] who demonstrated that a diet high in fat causes an increase in ALP levels in rats suffering from non-alcoholic fatty liver disease.

5. Conclusion

In conclusion, the present study showed the associations between macronutrient intake, gut microbiota, and serum lipid and enzyme profile in Wistar rats. The research thus far reveals that gut Microbiome, serum lipid and enzyme profile can respond to an altered diet, potentially facilitating the diversity of human dietary lifestyles. Gut microbial dysbiosis was found among all the groups as a shift in the microbiota composition was recorded. Indeed, macronutrient restriction affects lipid profile. HDL and triglyceride were highly affected by nutrient restriction. Groups that received diets high in macronutrient ratio had a greater effect on lipid profile than those on low macronutrient ratio. Serum enzymes were also affected by nutrient restriction. ALP was one enzyme found to be greatly affected by macronutrient restriction. Overall, we can conclude that current evidence for developing optimal dietary interventions targeting diet control via the gut microbiota is still in its infancy and does not capture the complexity of the integration of a whole-diet approach, the microbial and the host’s metabolic phenotype. Implementation of targeted, precision nutrition intervention strategies or dietary guidelines for individuals or subgroups in public health is still more remote and will require insight into the mechanisms involved in (non-) response to dietary intervention, implying that we need to go beyond prediction models. Detailed individual phenotyping and gaining insights into the balance between carbohydrate and protein fermentation by the gut microbiota as well as the site of fermentation in the colon are the key. The baseline gut microbial profile may be a predictor of an individual’s response to dietary interventions. Future research in this field should consider the detailed characterisation of both microbial and metabolic phenotypes as well as their interaction. Gut microbiome-associated effects on host metabolism may be related to fermentation products of carbohydrates and proteins. Understanding how to optimally balance proteolytic and saccharolytic fermentation and gaining insight into the importance of the site of colonic fermentation will give insight into the interplay between diet, gut microbiome and metabolic processes. Understanding the mechanisms of the differential responses to diet is essential to move forward in the field of precision nutrition. Although both the amount and quality of knowledge have evolved rapidly in recent years, we still only see the tip of the iceberg. Dietary macronutrients and the gut microbiome would be a precision nutrition approach to improve health.

Acknowledgements

Gratitude goes to Biaka University Institute of Buea and Agroecology Laboratory at the University of Buea for the realization of this work.

Conflicts of Interest

The authors declare no conflict of interest.

References

[1] D’Argenio, V. (2018) Human Microbiome Acquisition and Bioinformatic Challenges in Meta-Genomic Studies. International Journal of Molecular Sciences, 19, Article 383.
[CrossRef] [PubMed]
[2] Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.M., Kennedy, S., Leonard, P., Li, J., Burgdorf, K., Grarup, N., Jørgensen, T., Brandslund, I., Nielsen, H.B., Juncker, A.S., Bertalan, M., Levenez, F. and Pedersen, O. (2013) Richness of Human Gut Microbiome Correlates with Metabolic Markers. Nature, 500, 541-546.
[CrossRef] [PubMed]
[3] David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., Ling, A.V., Devlin, A.S., Varma, Y., Fischbach, M.A., Biddinger, S.B., Dutton, R.J. and Turnbaugh, P.J. (2014) Diet Rapidly and Reproducibly Alters the Human Gut Microbiome. Nature, 505, 559-563.
[CrossRef] [PubMed]
[4] Albenberg, L.G. and Wu, G.D. (2014) Diet and the Intestinal Microbiome: Associations, Functions, and Implications for Health and Disease. Gastroenterology, 146, 1564-1572.
[CrossRef] [PubMed]
[5] De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J.B., Massart, S., Collini, S., Pieraccini, G., and Lionetti, P. (2010) Impact of Diet in Shaping Gut Microbiota Revealed by a Comparative Study in Children from Europe and Rural Africa. Proceedings of the National Academy of Sciences of the United States of America, 107, 14691-14696.
[CrossRef] [PubMed]
[6] Hernandez, A.R., Kemp, K.M., Burke, S.N., Buford, T.W. and Carter, C.S. (2022) Influence of Aging, Macronutrient Composition and Time-Restricted Feeding on the Fischer344 x Brown Norway Rat Gut Microbiota. Nutrients, 14, Article 1758.
[CrossRef] [PubMed]
[7] Sbierski-Kind, J., Grenkowitz, S., Schlickeiser, S., Sandforth, A., Friedrich, M., Kunkel, D., Glauben, R., Brachs, S., Mai, K., Thürmer, A., Radonić, A., Drechsel, O., Turnbaugh, P.J., Bisanz, J.E., Volk, H.D., Spranger, J. and von Schwartzenberg, R.J. (2022) Effects of Caloric Restriction on the Gut Microbiome Are Linked with Immune Senescence. Microbiome, 10, Article No. 57.
[CrossRef] [PubMed]
[8] Muntner, P., He, J., Astor, B.C., Folsom, A.R. and Coresh, J. (2005) Traditional and Nontraditional Risk Factors Predict Coronary Heart Disease in Chronic Kidney Disease: Results from the Atherosclerosis Risk in Communities Study. Journal of the American Society of Nephrology, 16, 529-538.
[CrossRef]
[9] Johnson, A.J., Zheng J.J., Kang, J.W., Saboe, A., Knights, D. and Zivkovic, A.M. (2020) A Guide to Diet-Microbiome Study Design. Frontiers in Nutrition, 7, Article 79.
[CrossRef] [PubMed]
[10] Paris, J.M.G., Falkenberg, T., Nöthlings, U., Heinzel, C., Borgemeister, C. and Escobar, N. (2022) Changing Dietary Patterns Is Necessary to Improve the Sustainability of Western Diets from a One Health Perspective. The Science of the Total Environment, 811, Article 151437.
[CrossRef] [PubMed]
[11] Schwingshackl, L. and Hoffmann, G. (2013) Comparison of Effects of Long-Term Low-Fat vs High-Fat Diets on Blood Lipid Levels in Overweight or Obese Patients: A Systematic Review and Meta-Analysis. Journal of the Academy of Nutrition and Dietetics, 113, 1640-1661.
[CrossRef] [PubMed]
[12] Ramirez, J., Guarner, F., Bustos Fernandez, L., Maruy, A., Sdepanian, V.L. and Cohen, H. (2020) Antibiotics as Major Disruptors of Gut Microbiota. Frontiers in Cellular and Infection Microbiology, 10, Article 572912.
[CrossRef] [PubMed]
[13] Liu, X., Blouin, J., Santacruz, A., Lan, A., Andriamihaja, M., Wilkanowicz, S., et al. (2014) High-protein Diet Modifies Colonic Microbiota and Luminal Environment but Not Colonocyte Metabolism in the Rat Model: The Increased Luminal Bulk Connection. American Journal of Physiology-Gastrointestinal and Liver Physiology, 307, G459-G470.
[CrossRef] [PubMed]
[14] Brehm, B.J., Seeley, R.J., Daniels, S.R. and D’Alessio, D.A. (2003) A Randomized Trial Comparing a Very Low Carbohydrate Diet and a Calorie-Restricted Low Fat Diet on Body Weight and Cardiovascular Risk Factors in Healthy Women. The Journal of Clinical Endocrinology and Metabolism, 88, 1617-1623.
[CrossRef] [PubMed]
[15] Bajwa, A., Tan, S.T., Mehta, R. and Bahreyni, B. (2013) Rapid Detection of Viable Microorganisms Based on a Plate Count Technique Using Arrayed Microelectrodes. Sensors, 13, 8188-8198.
[CrossRef] [PubMed]
[16] Clarke, P.H. and Cowan, S.T. (1952) Biochemical Methods for Bacteriology. Journal of General Microbiology, 6, 187-197.
[CrossRef] [PubMed]
[17] Bucolo, G. and David, H. (1973) Quantitative Determination of Serum Triglycerides by the Use of Enzymes. Clinical Chemistry, 19, 476-482.
[CrossRef]
[18] Naito, H.K. (1984) High-Density Lipoprotein (HDL) Cholesterol. Clinical Chemistry, 437, 1207-1213.
[19] Tietz, N.W., et al. (1995) Clinical Guide to Laboratory Tests. 3rd Edition, AACC.
[20] Murray, R. (1984) Alanine Aminotransferase. Kaplan A et al. Clin Chem The C.V. Mosby Co., St Louis, Toronto, Princeton, 1088-1090.
[21] Harmsen, H.J., Wildeboer-Veloo, A.C., Raangs, G.C., Wagendorp, A.A., Klijn, N., Bindels, J.G. and Welling, G.W. (2000) Analysis of Intestinal Flora Development in Breast-Fed and Formula-Fed Infants by Using Molecular Identification and Detection Methods. Journal of Pediatric Gastroenterology and Nutrition, 30, 61-67.
[CrossRef] [PubMed]
[22] Noakes, M., Keogh, J.B., Foster, P.R. and Clifton, P.M. (2005) Effect of an Energy-Restricted, High-Protein, Low-Fat Diet Relative to a Conventional High-Carbohydrate, Low-Fat Diet on Weight Loss, Body Composition, Nutritional Status, and Markers of Cardiovascular Health in Obese Women. The American Journal of Clinical Nutrition, 81, 1298-1306.
[CrossRef] [PubMed]
[23] Ludwig, D.S., Willett, W.C., Volek, J.S. and Neuhouser, M.L. (2018) Dietary Fat: From Foe to Friend? Science, 362, 764-770.
[CrossRef] [PubMed]
[24] Westerterp-Plantenga, M.S., Nieuwenhuizen, A., Tomé, D., Soenen, S. and Westerterp, K.R. (2009) Dietary Protein, Weight Loss, and Weight Maintenance. Annual Review of Nutrition, 29, 21-41.
[CrossRef] [PubMed]
[25] Moon, J. and Koh, G. (2020) Clinical Evidence and Mechanisms of High-Protein Diet-Induced Weight Loss. Journal of Obesity & Metabolic Syndrome, 29, 166-173.
[CrossRef] [PubMed]
[26] Leidy, H.J., Armstrong, C.L., Tang, M., Mattes, R.D. and Campbell, W.W. (2010) The Influence of Higher Protein Intake and Greater Eating Frequency on Appetite Control in Overweight and Obese Men. Obesity, 18, 1725-1732.
[CrossRef] [PubMed]
[27] Solon-Biet, S.M., Mitchell, S.J., Coogan, S.C., Cogger, V.C., Gokarn, R., McMahon, A.C., Raubenheimer, D., de Cabo, R., Simpson, S.J. and Le Couteur, D.G. (2015) Dietary Protein to Carbohydrate Ratio and Caloric Restriction: Comparing Metabolic Outcomes in Mice. Cell Reports, 11, 1529-1534.
[CrossRef] [PubMed]
[28] Axen, K.V. and Axen, K. (2006) Very Low-Carbohydrate versus Isocaloric High-Carbohydrate Diet in Dietary Obese Rats. Obesity, 14, 1344-1352.
[CrossRef] [PubMed]
[29] Ble-Castillo, J.L., Aparicio-Trapala, M.A., Juárez-Rojop, I.E., Torres-Lopez, J.E., Mendez, J.D., et al. (2012) Differential Effects of High-Carbohydrate and High-Fat Diet Composition on Metabolic Control and Insulin Resistance in Normal Rats. International Journal of Environmental Research and Public Health, 9, 1663-1676.
[CrossRef] [PubMed]
[30] Lundsgaard, A.M., Holm, J.B., Sjøberg, K.A., Bojsen-Møller, K.N., Myrmel, L.S., Fjære, E., Jensen, B.A.H., Nicolaisen, T.S., Hingst, J.R., Hansen, S.L., Doll, S., Geyer, P.E., Deshmukh, A.S., Holst, J.J., Madsen, L., Kristiansen, K., Wojtaszewski, J.F.P., Richter, E.A. and Kiens, B. (2019) Mechanisms Preserving Insulin Action during High Dietary Fat Intake. Cell Metabolism, 29, 50-63.E4.
[CrossRef] [PubMed]
[31] Linn, T., Santosa, B., Grönemeyer, D., Aygen, S., Scholz, N., Busch, M. and Bretzel, R.G. (2000) Effect of Long-Term Dietary Protein Intake on Glucose Metabolism in Humans. Diabetologia, 43, 1257-1265.
[CrossRef] [PubMed]
[32] Wexler H.M. (2007) Bacteroides: The Good, the Bad, and the Nitty-Gritty. Clinical Microbiology Reviews, 20, 593-621.
[CrossRef]
[33] Wilkins, T.D., Wagner, D.L., Veltri, B.J., Jr. and Gregory, E.M. (1978) Factors Affecting Production of Catalase by Bacteroides. Journal of Clinical Microbiology, 8, 553-557.
[CrossRef] [PubMed]
[34] Biavati, B., Castagnoli, P., and Trovatelli, L.D. (1986) Species of the Genus Bifidobacterium in the Feces of Human Adults. Microbiologica, 9, 39-45.
[35] Holt-Harris, J.E. and Teague, O. (2016) A New Culture Medium for the Isolation of Bacillus Typhosus from Stools. The Journal of Infectious Diseases, 18, 596-600.
[CrossRef]
[36] Rothschild, D., Weissbrod, O., Barkan, E., Kurilshikov, A., Korem, T., Zeevi, D., Costea, P.I., Godneva, A., Kalka, I.N., Bar, N., Shilo, S., Lador, D., Vila, A.V., Zmora, N., Pevsner-Fischer, M., Israeli, D., Kosower, N., Malka, G., Wolf, B.C., Avnit-Sagi, T. and Segal, E. (2018) Environment Dominates over Host Genetics in Shaping Human Gut Microbiota. Nature, 555, 210-215.
[CrossRef] [PubMed]
[37] Matsumoto, K., Takada, T., Shimizu, K., Moriyama, K., Kawakami, K., Hirano, K., Kajimoto, O. and Nomoto, K. (2010) Effects of a Probiotic Fermented Milk Beverage Containing Lactobacillus casei strain Shirota on Defecation Frequency, Intestinal Microbiota, and the Intestinal Environment of Healthy Individuals with Soft Stools. Journal of Bioscience and Bioengineering, 110, 547-552.
[CrossRef] [PubMed]
[38] He, T., Priebe, M.G., Zhong, Y., Huang, C., Harmsen, H.J., Raangs, G.C., Antoine, J.M., Welling, G.W. and Vonk, R.J. (2008) Effects of Yogurt and Bifidobacteria Supplementation on the Colonic Microbiota in Lactose-Intolerant Subjects. Journal of Applied Microbiology, 104, 595-604.
[39] Zhong, Y., Huang, C.Y., He, T. and Harmsen, H.M. (2006) Effect of probiotics and yogurt on colonic microflora in subjects with lactose intolerance. Journal of Hygiene Research, 35, 587-591.
[40] Rodriguez, N.R. and Miller, S.L. (2015) Effective Translation of Current Dietary Guidance: Understanding and Communicating the Concepts of Minimal and Optimal Levels of Dietary Protein. The American Journal of Clinical Nutrition, 101, 1353S-1358S.
[CrossRef] [PubMed]
[41] Nordmann, P., Mariotte, S., Naas, T., Labia, R. and Nicolas, M.H. (1993) Biochemical Properties of a Carbapenem-Hydrolyzing Beta-Lactamase from Enterobacter Cloacae and Cloning of the Gene into Escherichia coli. Antimicrobial Agents and Chemotherapy, 37, 939-946.
[CrossRef] [PubMed]
[42] Wei, W., Wang, S., Xu, C., Zhou, X., Lian, X., He, L., et al. (2022) Gut Microbiota, Pathogenic Proteins and Neurodegenerative Diseases. Frontiers in Microbiology, 13, Article 959856.
[CrossRef] [PubMed]
[43] Wu, G. (2016) Dietary Protein Intake and Human Health. Food & Function, 7, 1251-1265.
[CrossRef] [PubMed]
[44] Mu, C., Yang, Y., Luo, Z. and Zhu, W. (2017) Temporal Microbiota Changes of High-Protein Diet Intake in a Rat Model. Anaerobe, 47, 218-225.
[CrossRef] [PubMed]
[45] Silva, Y.P., Bernardi, A. and Frozza, R.L. (2020) The Role of Short-Chain Fatty Acids from Gut Microbiota in Gut-Brain Communication. Frontiers in endocrinology, 11, Article 25.
[CrossRef] [PubMed]
[46] Vijay, N. and Morris, M.E. (2014) Role of Monocarboxylate Transporters in Drug Delivery to the Brain. Current Pharmaceutical Design, 20, 1487-1498.
[CrossRef] [PubMed]
[47] Schönfeld, P. and Wojtczak, L. (2016) Short and Medium-Chain Fatty Acids in Energy Metabolism: The Cellular Perspective. Journal of Lipid Research, 57, 943-954.
[CrossRef]
[48] Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.Y., Keilbaugh, S.A., Bewtra, M., Knights, D., Walters, W.A., Knight, R., Sinha, R., Gilroy, E., Gupta, K., Baldassano, R., Nessel, L., Li, H., Bushman, F.D. and Lewis, J.D. (2011) Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes. Science, 334, 105-108.
[CrossRef] [PubMed]
[49] Drasar, B.S., Crowther, J.S., Goddard, P., Hawksworth, G., Hill, M.J., Peach, S., Williams, R.E. and Renwick, A. (1973) The Relation between Diet and the Gut Microflora in Man. The Proceedings of the Nutrition Society, 32, 49-52.
[CrossRef]
[50] Murphy, E.F., Cotter, P.D., Healy, S., Marques, T.M., O’Sullivan, O., Fouhy, F., Clarke, S.F., O’Toole, P.W., Quigley, E.M., Stanton, C., Ross, P.R., O’Doherty, R.M. and Shanahan, F. (2010) Composition and Energy Harvesting Capacity of the Gut Microbiota: Relationship to Diet, Obesity and Time in Mouse Models. Gut, 59, 1635-1642.
[CrossRef] [PubMed]
[51] Lecomte, V., Kaakoush, N.O., Maloney, C.A., Raipuria, M., Huinao, K.D., Mitchell, H.M. and Morris, M.J. (2015) Changes in Gut Microbiota in Rats Fed a High Fat Diet Correlate with Obesity-Associated Metabolic Parameters. PLOS ONE, 10, e0126931.
[CrossRef] [PubMed]
[52] Hu, T., Mills, K.T., Yao, L., Demanelis, K., Eloustaz, M., Yancy Jr., W.S., Kelly, T. N., He, J. and Bazzano, L.A. (2012) Effects of Low-Carbohydrate Diets versus Low-Fat Diets on Metabolic Risk Factors: A Meta-Analysis of Randomized Controlled Clinical Trials. American journal of Epidemiology, 176, S44-S54.
[CrossRef] [PubMed]
[53] Bazzano, L.A., Hu, T., Reynolds, K., Yao, L., Bunol, C., Liu, Y., Chen, C.S., Klag, M.J., Whelton, P.K. and He, J. (2014) Effects of Low-Carbohydrate and Low-Fat Diets: A Randomized Trial. Annals of Internal Medicine, 161, 309-318.
[CrossRef]
[54] Cardillo, S., Seshadri, P. and Iqbal, N. (2006) The Effects of a Low-Carbohydrate versus Low-Fat Diet on Adipocytokines in Severely Obese Adults: Three-Year Follow-Up of a Randomized Trial. European Review for Medical and Pharmacological Sciences, 10, 99-106.
[55] Ma, Y., Li, Y., Chiriboga, D.E., Olendzki, B.C., Hebert, J.R., Li, W., Leung, K., Hafner, A.R. and Ockene, I.S. (2006) Association between Carbohydrate Intake and Serum Lipids. Journal of the American College of Nutrition, 25, 155-163.
[CrossRef] [PubMed]
[56] Ruottinen, S., Rönnemaa, T., Niinikoski, H., Lagström, H., Saarinen, M., Pahkala, K., Kaitosaari, T., Viikari, J. and Simell, O. (2009) Carbohydrate Intake, Serum Lipids and Apolipoprotein E Phenotype Show Association in Children. Acta Paediatrica, 98, 1667-1673.
[CrossRef] [PubMed]
[57] Parks E.J. (2001) Effect of Dietary Carbohydrate on Triglyceride Metabolism in Humans. The Journal of Nutrition, 131, 2772S–2774S.
[CrossRef]
[58] Siri, P.W. and Krauss, R.M. (2005) Influence of Dietary Carbohydrate and Fat on LDL and HDL Particle Distributions. Current Atherosclerosis Reports, 7, 455-459.
[CrossRef] [PubMed]
[59] Lichtenstein, A.H., Ausman, L.M., Carrasco, W., Jenner, J.L., Ordovas, J.M. and Schaefer, E.J. (1994) Short-Term Consumption of a Low-Fat Diet Beneficially Affects Plasma Lipid Concentrations Only When Accompanied by Weight Loss. Hypercholesterolemia, Low-Fat Diet, and Plasma Lipids. Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 14, 1751-1760.
[CrossRef]
[60] Kalaivanisailaja, J., Manju, V. and Nalini, N. (2003) Lipid Profile in Mice Fed a High-Fat Diet after Exogenous Leptin Administration. Polish Journal of Pharmacology, 55, 763-769.
[61] Bruna, M., Gumbau, V., Guaita, M., Canelles, E., Mulas, C., Basés, C., et al. (2014) Prospective Study of Gluco-Lipidic Hormone and Peptide Levels in Morbidly Obese Patients after Sleeve Gastrectomy. Cirugía Española (English Edition), 92, 175-181.
[CrossRef]
[62] Fontes, B.C., Anjos, J.S. D., Black, A.P., Moreira, N.X. and Mafra, D. (2018) Effects of Low-Protein Diet on Lipid and Anthropometric Profiles of Patients with Chronic Kidney Disease on Conservative Management. Journal Brasileiro de Nefrologia, 40, 225-232.
[CrossRef] [PubMed]
[63] Luna-Castillo, K.P., Olivares-Ochoa, X.C., Hernández-Ruiz, R.G., Llamas-Covarrubias, I.M., Rodríguez-Reyes, S.C., Betancourt-Núñez, A., Vizmanos, B., Martínez-López, E., Muñoz-Valle, J.F., Márquez-Sandoval, F. and López-Quintero, A. (2022) The Effect of Dietary Interventions on Hypertriglyceridemia: From Public Health to Molecular Nutrition Evidence. Nutrients, 14, Article 1104.
[CrossRef] [PubMed]
[64] Purkins, L., Love, E.R., Eve, M.D., Wooldridge, C.L., Cowan, C., Smart, T.S., Johnson, P.J. and Rapeport, W.G. (2004) The Influence of Diet upon Liver Function Tests and Serum Lipids in Healthy Male Volunteers Resident in a Phase I Unit. British Journal of Clinical Pharmacology, 57, 199-208.
[CrossRef] [PubMed]
[65] Welch-White, V., Dawkins, N., Graham, T. and Pace, R. (2013) The Impact of High Fat Diets on Physiological Changes in Euthyroid and Thyroid Altered Rats. Lipids in Health and Disease, 12, Article No. 100.
[CrossRef]
[66] Faye, B., Bengoumi, M., Faye, B. and Bengoumi, M. (2018) Clinical Enzymology. In: Camel Clinical Biochemistry and Hematology, Springer, 123-172.
[CrossRef]
[67] Zhou, Y., Ding, Y.L., Zhang, J.L., Zhang, P., Wang, J.Q. and Li, Z.H. (2018) Alpinetin Improved High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease (NAFLD) through Improving Oxidative Stress, Inflammatory Response and Lipid Metabolism. Biomedicine & Pharmacotherapy, 97, 1397-1408.
[CrossRef] [PubMed]

Copyright © 2026 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.